NASDAQ:ROKA - Sorrento Tech Stock Price, Price Target & More

$0.65 -0.02 (-2.99 %)

(As of 04/22/2018 04:00 PM ET)

Previous Close$0.65

Today's Range$0.65 - $0.69

52-Week Range$0.60 - $6.20

Volume242,292 shs

Average Volume371,374 shs

Market Capitalization$3.25 million

P/E RatioN/A

Dividend YieldN/A

Beta2.22

About Sorrento Tech (NASDAQ:ROKA)

Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Receive ROKA News and Ratings via Email

Sign-up to receive the latest news and ratings for ROKA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryN/A

SectorN/A

SymbolNASDAQ:ROKA

CUSIPN/A

Webwww.rokabio.com

Phone+1-908-6054700

Debt

Debt-to-Equity RatioN/A

Current Ratio1.25%

Quick Ratio0.60%

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$7.24 million

Price / Sales0.45

Cash FlowN/A

Price / CashN/A

Book Value$20.03 per share

Price / Book0.03

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-30,780,000.00

Net Margins3.30%

Return on Equity2.05%

Return on Assets1.00%

Miscellaneous

Employees90

Outstanding Shares5,010,000

How to Become a New Pot Stock Millionaire

Sorrento Tech (NASDAQ:ROKA) Frequently Asked Questions

What is Sorrento Tech's stock symbol?

Sorrento Tech trades on the NASDAQ under the ticker symbol "ROKA."

How were Sorrento Tech's earnings last quarter?

Sorrento Tech Inc (NASDAQ:ROKA) released its earnings results on Thursday, May, 11th. The medical research company reported ($1.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.19) by $0.34. The medical research company earned $2.04 million during the quarter. Sorrento Tech had a net margin of 3.30% and a return on equity of 2.05%. View Sorrento Tech's Earnings History.

Who are some of Sorrento Tech's key competitors?

Some companies that are related to Sorrento Tech include Heat Biologics (HTBX), Amedica (AMDA), Apricus Biosciences (APRI), Rex Energy (REXX), STRATA Skin Sciences (SSKN), Avinger (AVGR), Westmoreland Coal (WLB), Orexigen Therapeutics (OREX), Inpixon (INPX), Dextera Surgical (DXTR), Argos Therapeutics (ARGS), Rosetta Genomics (ROSG), Recon Capital Series Trust Recon Capital FTSE 100 ETF (UK), Global Brokerage (GLBR), Great Basin Scientific (GBSN), Rand Logistics (RLOG), 1st Century Bancshares (FCTY) and Accelrys (ACCL).

Who are Sorrento Tech's key executives?

Sorrento Tech's management team includes the folowing people:

Paul G. Thomas, Chairman of the Board (Age 61)
Mary Duseau, President, Chief Executive Officer, Secretary, Director (Age 52)
Lars Boesgaard, Chief Financial Officer, Vice President, Treasurer (Age 47)
Nicholas J. Valeriani, Director (Age 60)
Michael P. Doyle Ph.D., Independent Director (Age 67)
David W. J. McGirr, Independent Director (Age 62)

Has Sorrento Tech been receiving favorable news coverage?

Headlines about ROKA stock have been trending somewhat positive on Sunday, according to Accern. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Sorrento Tech earned a news impact score of 0.15 on Accern's scale. They also assigned press coverage about the medical research company an impact score of 45.30 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Sorrento Tech?

Shares of ROKA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sorrento Tech's stock price today?

One share of ROKA stock can currently be purchased for approximately $0.65.

How big of a company is Sorrento Tech?

Sorrento Tech has a market capitalization of $3.25 million and generates $7.24 million in revenue each year. Sorrento Tech employs 90 workers across the globe.

How can I contact Sorrento Tech?

Sorrento Tech's mailing address is 20 Independence Blvd, WARREN, NJ 07059-2731, United States. The medical research company can be reached via phone at +1-908-6054700 or via email at [email protected]

MarketBeat Community Rating for Sorrento Tech (ROKA)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		116 (Vote Outperform)
Underperform Votes:		131 (Vote Underperform)
Total Votes:		247

MarketBeat's community ratings are surveys of what our community members think about Sorrento Tech and other stocks. Vote "Outperform" if you believe ROKA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ROKA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Sorrento Tech (NASDAQ:ROKA) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	N/A	N/A	N/A	Buy
Consensus Rating Score:	N/A	N/A	N/A	3.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	N/A	$10.00
Price Target Upside:	N/A	N/A	N/A	132.56% upside

Sorrento Tech (NASDAQ:ROKA) Consensus Price Target History

Price Target History for Sorrento Tech (NASDAQ:ROKA)

Sorrento Tech (NASDAQ:ROKA) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
12/12/2016	Roth Capital	Initiated Coverage	Buy	$10.00	N/A

(Data available from 4/22/2016 forward)

Sorrento Tech (NASDAQ:ROKA) Earnings History and Estimates Chart

Earnings by Quarter for Sorrento Tech (NASDAQ:ROKA)

Sorrento Tech (NASDAQ ROKA) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/13/2017	Q3 2017		($1.28)		$1.91 million	View	N/A
8/18/2017	Q2 2017		($1.23)		$2.14 million	View	N/A
5/11/2017	Q1 2017	($1.19)	($1.53)		$2.04 million	View	N/A
3/9/2017	Q4 2016		($3.72)		$1.91 million	View	N/A
11/7/2016	Q316		($5.39)	$1.50 million	$1.90 million	View	Listen
8/5/2016	Q2 2016	($5.10)	($4.30)		$1.82 million	View	N/A
5/4/2016	Q116	($0.46)	($0.47)	$1.56 million	$1.60 million	View	N/A
3/4/2016	Q415	($0.48)	($0.56)	$1.63 million	$1.50 million	View	N/A
11/11/2015	Q315	($0.53)	($0.49)	$1.75 million	$1.50 million	View	N/A
8/13/2015	Q215	($0.51)	($0.54)	$1.58 million	$1.50 million	View	N/A
5/7/2015	Q115	($0.50)	($0.51)	$1.44 million	$1.51 million	View	N/A
3/26/2015	Q414	($0.52)	($0.43)	$1.44 million	$1.36 million	View	N/A
11/6/2014		($0.49)	($0.64)	$2.11 million	$1.48 million	View	N/A
8/11/2014	Q214		($11.28)		$1.40 million	View	N/A

(Earnings results data provided by Zacks Investment Research)

Sorrento Tech (NASDAQ:ROKA) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Sorrento Tech (NASDAQ ROKA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 29.20%
Institutional Ownership Percentage: 48.14%

Insider Trading History for Sorrento Tech (NASDAQ:ROKA)

Sorrento Tech (NASDAQ ROKA) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
10/3/2017	Orbimed Advisors Llc	Major Shareholder	Sell	201,617	$0.68	$137,099.56
9/29/2017	Orbimed Advisors Llc	Major Shareholder	Sell	474,676	$0.72	$341,766.72
9/27/2017	Orbimed Advisors Llc	Major Shareholder	Sell	127,601	$0.98	$125,048.98
8/24/2017	Orbimed Advisors Llc	Major Shareholder	Sell	14,300	$1.50	$21,450.00
8/23/2017	Orbimed Advisors Llc	Major Shareholder	Sell	1,100	$1.50	$1,650.00
8/22/2017	Orbimed Advisors Llc	Major Shareholder	Sell	75,276	$1.52	$114,419.52
11/17/2014	David W J Mcgirr	Director	Buy	50,000	$3.60	$180,000.00
7/22/2014	Patrick J Kerins	Major Shareholder	Buy	383,333	$12.00	$4,599,996.00

(Data available from 1/1/2013 forward)

Sorrento Tech (NASDAQ ROKA) News Headlines

Source:

Date	Headline
	Repros Therapeutics (RPRX) and Sorrento Tech (ROKA) Head-To-Head Analysis www.americanbankingnews.com - March 20 at 5:18 AM
	Financial Review: GenVec (GNVC) and Sorrento Tech (ROKA) www.americanbankingnews.com - March 19 at 9:42 AM
	Critical Contrast: Repros Therapeutics (RPRX) & Sorrento Tech (ROKA) www.americanbankingnews.com - March 18 at 11:28 PM
	Sorrento Tech Inc (ROKA) Is Going Private; Shares Plunge finance.yahoo.com - December 20 at 3:54 PM
	Sorrento Tech, Inc. Announces Voluntary Delisting from Nasdaq and Closing of ... www.prnewswire.com - December 20 at 11:07 AM
	Roka Bioscience (ROKA) Announces Voluntary Delisting from Nasdaq www.streetinsider.com - December 20 at 11:07 AM
	Sorrento Tech, Inc. Announces Voluntary Delisting from Nasdaq and Closing of its Stock Transfer Books finance.yahoo.com - December 20 at 11:07 AM
	Sorrento Tech Inc (NASDAQ:ROKA): Should The Recent EPS Drop Worry You? finance.yahoo.com - December 19 at 3:53 PM
	Reviewing Roka Bioscience (ROKA) and Its Competitors www.americanbankingnews.com - November 30 at 11:24 PM
	Sorrento Tech, Inc. :ROKA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 finance.yahoo.com - November 29 at 11:10 AM
	Head to Head Comparison: Roka Bioscience (ROKA) and The Competition www.americanbankingnews.com - November 7 at 11:36 PM
	What Investors Should Know About Roka Bioscience Inc’s (ROKA) Financial Strength finance.yahoo.com - November 4 at 12:17 PM
	BRIEF-Edward Painter dissolves share stake in Roka Bioscience www.reuters.com - October 24 at 9:25 AM
	BRIEF-Edward Painter dissolves share stake in Roka Bioscience www.reuters.com - October 24 at 9:25 AM
	BRIEF-Edward Painter reports 6.79 pct stake in Roka Bioscience www.reuters.com - October 11 at 7:15 AM
	Head to Head Review: Agenus (AGEN) versus Roka Bioscience (ROKA) www.americanbankingnews.com - October 7 at 8:24 PM
	BRIEF-Orbimed Advisors cuts stake in Roka Bioscience to 10.24 pct - SEC filing www.reuters.com - October 6 at 7:28 AM
	Roka Bioscience, Inc. (ROKA) Major Shareholder Sells $137,099.56 in Stock www.americanbankingnews.com - October 5 at 7:46 PM
	Roka Bioscience, Inc. (ROKA) Major Shareholder Orbimed Advisors Llc Sells 474,676 Shares www.americanbankingnews.com - October 2 at 7:43 PM
	ROKA BIOSCIENCE, INC. - StreetInsider.com www.streetinsider.com - September 28 at 8:03 PM
	Orbimed Advisors Llc Sells 127,601 Shares of Roka Bioscience, Inc. (ROKA) Stock www.americanbankingnews.com - September 28 at 7:48 PM
	Roka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 finance.yahoo.com - August 26 at 8:55 AM
	Roka Bioscience, Inc. (ROKA) Major Shareholder Sells $21,450.00 in Stock www.americanbankingnews.com - August 25 at 4:32 PM
	Roka Bioscience, Inc. (ROKA) Major Shareholder Sells $114,419.52 in Stock www.americanbankingnews.com - August 22 at 10:20 PM
	Roka Bioscience (ROKA) to Sell its Assets to Subsidiary of Institute for Environmental Health for $17.5M www.streetinsider.com - August 17 at 9:13 PM
	BRIEF-Roka Bioscience agrees to sell its assets to subsidiary of Institute for Environmental Health www.reuters.com - August 17 at 9:13 PM
	Roka Bioscience, Inc. Agrees to Sell its Assets to Subsidiary of Institute for Environmental Health, Inc. finance.yahoo.com - August 17 at 4:12 PM
	BRIEF-Tamim Shansab reports 5.4 pct passive stake in Roka Bioscience www.reuters.com - July 29 at 6:52 AM
	Roka Bioscience to Co-Present Industry Webinar - Game of Zones: A Practical Guide to Listeria Monitoring and Detection finance.yahoo.com - July 27 at 6:57 AM
	Roka Bioscience Announces AOAC Certification for 18-hour Sample Enrichment using ActeroTM ELITE Listeria Enrichment Media and the Atlas® Listeria Environmental Assay finance.yahoo.com - July 11 at 4:33 PM
	Roka Bioscience to Present at the International Association of Food Protection Conference finance.yahoo.com - July 8 at 2:07 PM
	Roka Bioscience (ROKA) Enters Distribution Partnership with FoodChek Systems www.streetinsider.com - May 9 at 10:45 AM
	BRIEF-Roka Bioscience says entered into 5-year non-exclusive distribution agreement with Foodchek Systems Inc www.reuters.com - May 9 at 10:45 AM
	Food Safety Testing Market Size to Reach USD 8.04 Billion by 2021: Zion Market Research globenewswire.com - April 28 at 3:44 PM
	Roka Bioscience to participate in the 40th Annual National Food Policy Conference - PR Newswire (press release) www.prnewswire.com - April 11 at 9:57 AM
	Roka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 24, 2017 us.rd.yahoo.com - March 24 at 7:25 PM
	ROKA BIOSCIENCE, INC. Files SEC form 10-K, Annual Report biz.yahoo.com - March 20 at 5:40 PM
	Roka Bioscience Reports Fourth Quarter and Full Year 2016 Financial Results us.rd.yahoo.com - March 9 at 7:34 PM
	Q4 2016 Roka Bioscience Inc Earnings Release - After Market Close biz.yahoo.com - March 9 at 8:09 AM
	ROKA BIOSCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements a biz.yahoo.com - March 1 at 10:13 AM
	4:16 pm Roka Bioscience appoints Mary Duseau as President and CEO effective today us.rd.yahoo.com - January 18 at 12:58 AM
	ROKA BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit biz.yahoo.com - January 17 at 7:56 PM
	ROKA BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly Report biz.yahoo.com - November 8 at 7:01 PM
	ROKA BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition biz.yahoo.com - November 7 at 8:01 PM
	Q3 2016 Roka Bioscience Inc Earnings Release - After Market Close biz.yahoo.com - November 7 at 11:09 AM
	ROKA BIOSCIENCE, INC. Files SEC form 8-K, Other Events biz.yahoo.com - November 1 at 7:25 PM
	Roka Bioscience to Report Third Quarter 2016... www.benzinga.com - October 31 at 6:56 PM
	Leading Subject Matter Experts Will Address Key Issues and Solutions at Food Safety Summit Resource Center at PACK EXPO www.finanznachrichten.de - October 27 at 7:13 PM
	Roka Bioscience (ROKA) to Effect 1-for-10 Reverse Stock Split www.streetinsider.com - October 12 at 7:02 PM
	ROKA BIOSCIENCE, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year biz.yahoo.com - October 11 at 7:26 PM

Sorrento Tech (NASDAQ:ROKA) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Sorrento Tech (NASDAQ:ROKA) Income Statement, Balance Sheet and Cash Flow Statement

Sorrento Tech (NASDAQ ROKA) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff